Clinical aspects and risk factors of nosocomial Stenotrophomonas maltophilia bacteremia episodes in a Turkish intensive care unit

Journal of Chemotherapy

Volumn 19, Issue 6, 2007, Pages 658-664

  Tunger, Ozlem ^a   Vural, S ^a   Cetin, C B ^a   Keles, G ^a   Borand, H ^a   Gazi, H ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Intensive care unit; Nosocomial bacteremia; Stenotrophomonas maltophilia

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; NETILMICIN; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; TIMENTIN; TOBRAMYCIN;

ADULT; AGED; ANEMIA; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; CENTRAL VENOUS CATHETER; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DISEASE PREDISPOSITION; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; INTENSIVE CARE UNIT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MICROBIOLOGICAL EXAMINATION; MORTALITY; OUTCOME ASSESSMENT; RESPIRATORY TRACT INFECTION; RISK FACTOR; STENOTROPHOMONAS MALTOPHILIA; TOTAL PARENTERAL NUTRITION; TURKEY (REPUBLIC);

EID: 38949129340     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.6.658     Document Type: Article

References (27)

1. Denton M, Kerr KG. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev 1998; 11: 57-80.
2. Marshall WF, Keating MR, Anhalt JP, Steckelberg JM. Xanthomonas maltophilia: an emerging nosocomial pathogen. Mayo Clin Proc 1989; 64: 1097-1104.
3. Muder RR, Yu VL, Dummer JS, Vinson C, Lumish RM. Infections caused by Pseudomonas maltophilia: expanding clinical spectrum. Arch Intern Med 1987; 147: 1672-1674.
4. Rello J, Ricart M, Mirelis B, et al. Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med 1994; 20: 94-98.
5. Krcmery V, Pichna P, Oravcoca E, et al. Stenotrophomonas maltophilia bacteremia in cancer patients: report on 31 cases. J Hosp Infect 1996; 34: 75-77.
6. Elting LS, Khardori N, Bodey GP, Fainstein V. Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of predisposing factors. Infect Control Hosp Epidemiol 1990; 11: 134-138.
7. Alonso A, Martinez JL. Multipl antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 1997; 41: 1140-1142.
8. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128-140.
9. Sherertz RJ. Surveillance for infections associated with vascular catheters: Infect Control Hosp Epidemiol 1996; 17: 746-752.
10. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease clacification system. Crit Care Med 1985; 13: 818-29.
11. Micozzi A, Venditti M, Monaco M, et al. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 2000; 31: 705-711.
12. Muder RR, Haris AP, Muller S, et al. Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: A prospective, multicenter study of 91 episodes. Clin Infcet Dis 1996; 22: 508-512.
13. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: Sixteenth informational supplement. CLSI document M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA, USA; 2006.
14. Elting LS, Bodey GP. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: increasing incidence of catheter-related infections. Medicine 1990; 69: 296-306.
15. Khardori N, Elting L, Wong E, Schable B, Bodey GP. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis 1990; 12: 997-1003.
16. Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: Geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999). Clin Infect Dis 2001; 32 (Suppl 2): S104-113.
17. Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis 2002; 34: 1653-1656.
18. Lai CH, Chi CY, Chen HP, et al. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect 2004; 37: 350-358.
19. Hanes SD, Demirkan K, Tolley E, et al. Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients. Clin Infect Dis 2002; 35: 228-235.
20. Schaumann R, Stein K, Eckhardt C, Ackermann G, Rodloff AC. Infections caused by Stenotrophomonas maltophilia - a prospective study. Infection 2001; 29: 205-208.
21. Friedman ND, Korman TM, Fairley CK, Franklin JC, Spelman DW. Bacteremia due to Stenotrophomonas maltophilia: An analysis of 45 episodes. J Infection 2002; 45: 47-53.
22. Khardori N, Reuben A, Rosenbaum B, Rolston K, Bodey GP. In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents. Antimicrob Agents Chemother 1990; 34: 1609-1610.
23. Wang WS, Liu CP, Lee CM, Huang FY. Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan. J Microbiol Immunol Infect 2004; 37: 359-365.
24. Krueger TS, Clark EA, Nix DE. In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations. Diagn Microbial Infect Dis 2001; 41: 71-78.
25. Zhang L, Li XZ, Poole K. Multiple antibiotic resistance in Stenotrophomonas maltophilia: Involvement of a multidrug efflux system. Antimicrob Agents Chemother 2000; 44: 287-293.
26. Bellido JL, Hernandez FJ, Zufiaurre MN, Garcia-Rodrigez JA: In vitro activity of newer fluoroquinolones against Stenotrophomonas maltophilia: J Antimicrob Chemother 2000; 46: 334-335.
27. Sattler CA, Mason EO, Kaplan SL. Nonrespiratory Stenotrophomonas maltophilia infection at a children's hospital. Clin Infect Dis 2000; 31: 1321-1330.